MEDICAL DEVICE MANUFACTURERS ASSOCIATION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
LMH STRATEGIC SOLUTIONS	—	12

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	11
SENATE	11

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	12
Medicare/Medicaid	Medicare/Medicaid	3

Bills Explicitly Cited (10)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2026 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. Issues related to medical devices. Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to physician fee schedule. Issues related to coverage of telehealth services. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). Supply chain issues. Cyber security issues related to consumer and health data privacy. TCET Issues related to the New Technology Add on Payment (NTAP).

Client expense: — · Firm income: $20,000

Matched citations: H.R. 1691

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2026 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. Issues related to medical devices. Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to physician fee schedule. Issues related to coverage of telehealth services. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). Supply chain issues. Cyber security issues related to consumer and health data privacy. TCET Issues related to the New Technology Add on Payment (NTAP).

Client expense: — · Firm income: $20,000

Matched citations: H.R. 1691

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2026 · first_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. Issues related to medical devices. Issues related to FDA approval of medical devices. Issues related to sterilization of medical devices. Barriers to market access for medical device companies. Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to physician fee schedule. Issues related to coverage of telehealth services. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Issues related to Transitional Coverage for Emerging Technologies (TCET)(CMS-3421-NC). Supply chain issues. Cyber security issues related to consumer and health data privacy. TCET Issues related to the New Technology Add on Payment (NTAP).

Client expense: — · Firm income: $20,000

Matched citations: H.R. 1691

H.R. 1539119th Congress

Medical Device Electronic Labeling Act

2025 · fourth_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. Issues related to medical devices. H.R.1539 - Medical Device Electronic Labeling Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Supply chain issues. Cyber security issues related to consumer and health data privacy.

Client expense: — · Firm income: $20,000

Matched citations: H.R.1539

Show 6 more cited filings

H.R. 1539119th Congress

Medical Device Electronic Labeling Act

2025 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. Issues related to medical devices. H.R.1539 - Medical Device Electronic Labeling Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Supply chain issues. Cyber security issues related to consumer and health data privacy.

Client expense: — · Firm income: $20,000

Matched citations: H.R.1539

H.R. 1539119th Congress

Medical Device Electronic Labeling Act

2025 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. Issues related to medical devices. H.R.1539 - Medical Device Electronic Labeling Act. Issues related to Medical Device User Fee Amendments (MDUFA) implementation. Issues related to regulation and reimbursement of artificial intelligence in healthcare. Supply chain issues. Cyber security issues related to consumer and health data privacy.

Client expense: — · Firm income: $20,000

Matched citations: H.R.1539

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2024 · fourth_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET.

Client expense: — · Firm income: $20,000

Matched citations: H.R.1691

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2024 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET.

Client expense: — · Firm income: $20,000

Matched citations: H.R.1691

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2024 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET.

Client expense: — · Firm income: $20,000

Matched citations: H.R.1691

H.R. 1691118th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

2024 · first_quarter · Firm: LMH STRATEGIC SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

Health programs impacting MDMA. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023, Ethylene Oxide (EtO), TCET.

Client expense: — · Firm income: $10,000

Matched citations: H.R.1691

Source: Senate LDA

MEDICAL DEVICE MANUFACTURERS ASSOCIATION — Lobbying Disclosure | Poliscope